#!/usr/bin/env python3
"""
Menopause KP-CDST: Clinical Decision Support Tool
===================================================
Streamlit app for clinicians to input patient profile and receive
a KP risk assessment with treatment pathway recommendation and
cost-offset analysis.

Foundation: Metri et al. (2023) normative KP data (N=8,089)
COI Model: Gannott (2025) â€” First published COI for menopausal
           cognitive & mood symptoms (Australia)

Usage:
    pip install streamlit plotly pandas
    streamlit run Menopause_KP_CDST.py
"""

import streamlit as st
import pandas as pd
import plotly.graph_objects as go
import plotly.express as px
import numpy as np

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# PAGE CONFIG
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
st.set_page_config(
    page_title="Menopause KP-CDST",
    page_icon="ğŸ§ ",
    layout="wide",
    initial_sidebar_state="expanded"
)

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# NORMATIVE DATA (Metri et al. 2023, Int J Tryptophan Res)
# N=8,089 across 120 studies, 31 countries
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

# Grand weighted means Â± SD
NORM = {
    'serum_trp': {'mean': 60.52, 'sd': 15.38, 'unit': 'Î¼M', 'label': 'Serum Tryptophan'},
    'serum_kyn': {'mean': 1.96, 'sd': 0.51, 'unit': 'Î¼M', 'label': 'Serum Kynurenine'},
    'plasma_trp': {'mean': 51.45, 'sd': 10.47, 'unit': 'Î¼M', 'label': 'Plasma Tryptophan'},
    'plasma_kyn': {'mean': 1.82, 'sd': 0.54, 'unit': 'Î¼M', 'label': 'Plasma Kynurenine'},
}

# Australian-specific normative ranges (Metri 2023, regional data)
NORM_AU = {
    'serum_trp': {'mean': 67.26, 'sd': 11.19, 'unit': 'Î¼M'},
    'serum_kyn': {'mean': 2.43, 'sd': 0.59, 'unit': 'Î¼M'},
    'plasma_trp': {'mean': 42.87, 'sd': 8.51, 'unit': 'Î¼M'},
    'plasma_kyn': {'mean': 2.12, 'sd': 0.52, 'unit': 'Î¼M'},
}

# Age regression coefficients (Metri 2023)
AGE_EFFECTS = {
    'serum_trp':  {'beta': -0.20, 'p': 0.036},
    'serum_kyn':  {'beta': 0.01, 'p': 0.002},
    'plasma_trp': {'beta': -0.74, 'p': 0.001},
    'plasma_kyn': {'beta': 0.02, 'p': 0.001},
}

# Sex effects (female vs male)
SEX_EFFECTS = {
    'serum_trp':  {'beta': -0.22, 'p': 0.012},
    'serum_kyn':  {'beta': -0.05, 'p': 0.001},
}

# KP-linked conditions and their AU annual burden
KP_CONDITIONS = {
    'Major Depression': {'burden_b': 12.6, 'kp_link': 'Elevated KYN/TRP; reduced serotonin', 'risk_hr': 2.5, 'evidence': 'A'},
    'Alzheimer\'s/Dementia': {'burden_b': 18.0, 'kp_link': 'Neurotoxic QUIN accumulation', 'risk_hr': 1.46, 'evidence': 'A'},
    'Type 2 Diabetes': {'burden_b': 6.3, 'kp_link': 'IDO upregulation; insulin resistance', 'risk_hr': 1.3, 'evidence': 'B'},
    'Cardiovascular Disease': {'burden_b': 12.5, 'kp_link': 'KYN predicts cardiovascular events', 'risk_hr': 1.4, 'evidence': 'A'},
    'Anxiety Disorders': {'burden_b': 5.8, 'kp_link': 'Serotonin depletion via KP shunt', 'risk_hr': 1.58, 'evidence': 'A'},
    'Osteoporosis': {'burden_b': 3.4, 'kp_link': 'TRPâ†’serotoninâ†’bone metabolism', 'risk_hr': 1.2, 'evidence': 'B'},
}

# Treatment options
TREATMENTS = {
    'iTBS': {
        'label': 'Intermittent Theta-Burst Stimulation',
        'annual_cost': 7500, 'mbs_rebate': 4080,
        'oop': 3420, 'evidence_mood': 'B', 'evidence_cog': 'GAP',
        'desc': 'Non-invasive brain stimulation targeting DLPFC. MBS Items 14216-14220. '
                'MenoStim trial (Metri PhD, NICM HRI) is FIRST to test for menopausal symptoms.',
        'color': '#E74C3C',
    },
    'MHT (HRT)': {
        'label': 'Menopausal Hormone Therapy',
        'annual_cost': 380, 'mbs_rebate': 0,
        'oop': 380, 'evidence_mood': 'A', 'evidence_cog': 'B',
        'desc': 'Estrogen Â± progesterone. PBS $31.60/mo from March 2025. '
                'First-line for VMS; may benefit mood and cognition during critical window (Maki 2013).',
        'color': '#3498DB',
    },
    'SSRI/SNRI': {
        'label': 'Antidepressant Medication',
        'annual_cost': 300, 'mbs_rebate': 0,
        'oop': 300, 'evidence_mood': 'A', 'evidence_cog': 'D',
        'desc': 'Escitalopram, desvenlafaxine. PBS generic. Evidence for mood but NOT cognition. '
                'May worsen cognitive symptoms in some women.',
        'color': '#F39C12',
    },
    'CBT (Better Access)': {
        'label': 'Cognitive Behavioural Therapy',
        'annual_cost': 560, 'mbs_rebate': 560,
        'oop': 0, 'evidence_mood': 'A', 'evidence_cog': 'C',
        'desc': 'MBS Better Access: 6 sessions/yr. Evidence for mood and hot flush coping. '
                'Limited direct evidence for menopausal cognitive symptoms.',
        'color': '#27AE60',
    },
    'Monitoring Only': {
        'label': 'Watchful Waiting + Lifestyle',
        'annual_cost': 320, 'mbs_rebate': 165,
        'oop': 155, 'evidence_mood': 'C', 'evidence_cog': 'C',
        'desc': 'GP monitoring + lifestyle (exercise, sleep, stress management). '
                'Cognitive symptoms are transient â€” reverse postmenopause (SWAN longitudinal).',
        'color': '#95A5A6',
    },
}

# Productivity loss (from COI Stromberg decomposition, Stromberg et al. 2017)
PER_WOMAN_INDIRECT = 25_917  # AUD/yr (Stromberg-adjusted)
STROMBERG = {
    'Base_A': 196,       # Employee absenteeism
    'Employer_A': 190,   # Employer replacement (SA=0.97)
    'Base_P': 13_166,    # Employee presenteeism
    'Employer_P': 7_110, # Employer friction (SP=0.54)
    'WEP': 5_256,        # Workplace environment problems (SWEP=0.72 x employer-side)
}

# Treatment evidence matrix (0-10 scale for radar chart)
TX_EVIDENCE = {
    'iTBS': {'mood': 6, 'cognition': 3, 'vms': 1, 'cost_eff': 5, 'access': 4, 'safety': 8},
    'MHT (HRT)': {'mood': 7, 'cognition': 6, 'vms': 10, 'cost_eff': 9, 'access': 9, 'safety': 7},
    'SSRI/SNRI': {'mood': 9, 'cognition': 2, 'vms': 5, 'cost_eff': 9, 'access': 10, 'safety': 6},
    'CBT (Better Access)': {'mood': 8, 'cognition': 4, 'vms': 6, 'cost_eff': 8, 'access': 7, 'safety': 10},
    'Monitoring Only': {'mood': 2, 'cognition': 3, 'vms': 1, 'cost_eff': 10, 'access': 10, 'safety': 10},
}

# ARIA-H / Neurovascular risk data
DEMENTIA_LIFETIME_COST = 442_000  # AUD, NATSEM estimate
ARIA_H_PREV_POSTMENO = 0.12  # ~10-15% cerebral microbleeds in postmenopausal women
KP_POSITIVE_PREV = 0.30  # GAP estimate â€” KP dysregulation in perimenopausal women

# Research gaps â€” for the Gaps tab
RESEARCH_GAPS = [
    {
        'gap': 'KP dysregulation prevalence in perimenopausal women',
        'current': '30% estimate (GAP) â€” extrapolated from Metri 2023 age-sex regression, not menopause-specific',
        'fundable': 'Cross-sectional KP profiling of 200-500 women stratified by menopausal stage (STRAW+10)',
        'fills': 'BIM population funnel; CDST threshold calibration',
        'owner': 'MenoStim trial can answer this with baseline KP data from n=72',
        'priority': 'HIGH',
    },
    {
        'gap': 'Cognitive symptom attribution to productivity loss',
        'current': '35% estimate (GAP) â€” based on Griffiths 2013 UK survey, not validated',
        'fundable': 'WPAI-M (menopause-specific work productivity instrument) validation study',
        'fills': 'COI cognitive burden sheet; per-symptom economic attribution',
        'owner': 'Could be nested within MenoStim as secondary outcome',
        'priority': 'HIGH',
    },
    {
        'gap': 'iTBS efficacy for menopausal cognitive/mood symptoms',
        'current': 'NO DATA â€” MenoStim is the FIRST trial',
        'fundable': 'Phase III multi-site RCT following MenoStim pilot (n=72)',
        'fills': 'BIM efficacy parameter; CDST treatment ranking validation',
        'owner': 'Metri PhD â€” MenoStim trial (ACTRN12625000030471)',
        'priority': 'CRITICAL',
    },
    {
        'gap': 'KP biomarker response to iTBS',
        'current': 'No data on whether iTBS modifies KYN/TRP ratio',
        'fundable': 'Pre/post KP profiling within MenoStim (add-on to existing protocol)',
        'fills': 'Mechanistic link; CDST biomarker-guided selection validation',
        'owner': 'Metri â€” if MenoStim collects bloods pre/post, this is answerable',
        'priority': 'CRITICAL',
    },
    {
        'gap': 'Menopause-attributable fraction for dementia',
        'current': '3% estimate (GAP) â€” speculative, from Rocca observational HRs',
        'fundable': 'Longitudinal cohort linking perimenopause KP levels to 10-year dementia incidence',
        'fills': 'Dementia cost avoidance model; VDC estimation',
        'owner': 'Requires ALSWH or 45-and-Up linkage â€” beyond single trial',
        'priority': 'MEDIUM',
    },
    {
        'gap': 'KYNA/QUIN ratio in menopausal women',
        'current': 'Metri 2023 measured TRP and KYN only â€” not downstream metabolites',
        'fundable': 'Extended KP metabolome (KYNA, QUIN, 3-HK, picolinic acid) in menopause cohort',
        'fills': 'Neuroprotective vs neurotoxic balance; precision risk stratification',
        'owner': 'Metri 2023 explicitly recommends this as future work',
        'priority': 'HIGH',
    },
    {
        'gap': 'ARIA-H prevalence in KP-dysregulated perimenopausal women',
        'current': 'No data linking cerebral microbleeds to KP status in menopause â€” separate literatures',
        'fundable': 'MRI substudy within MenoStim (n=72): brain MRI + KP bloods at baseline and post-iTBS',
        'fills': 'Triple-hit model validation; neurovascular risk stratification; dementia cost avoidance denominator',
        'owner': 'Nestable within MenoStim if MRI added to protocol; or ALSWH/45-and-Up linkage study',
        'priority': 'CRITICAL',
    },
]

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# HELPER FUNCTIONS
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

def z_score(value, mean, sd):
    """Compute z-score from normative data."""
    if sd == 0:
        return 0
    return (value - mean) / sd

def kp_risk_score(trp, kyn, sample_type='serum', use_au=True, patient_age=51):
    """
    Compute KP risk score from TRP and KYN values.
    Age-adjusted using Metri 2023 regression coefficients.

    Returns dict with z-scores, KYN/TRP ratio, risk level, and interpretation.
    """
    norms = NORM_AU if use_au else NORM
    trp_key = f'{sample_type}_trp'
    kyn_key = f'{sample_type}_kyn'

    # Age-adjusted normative means (Metri 2023 regression)
    adj_trp_mean = age_adjust(patient_age, norms[trp_key]['mean'], AGE_EFFECTS[trp_key]['beta'])
    adj_kyn_mean = age_adjust(patient_age, norms[kyn_key]['mean'], AGE_EFFECTS[kyn_key]['beta'])

    trp_z = z_score(trp, adj_trp_mean, norms[trp_key]['sd'])
    kyn_z = z_score(kyn, adj_kyn_mean, norms[kyn_key]['sd'])

    # KYN/TRP ratio (higher = more KP activation = more risk)
    kyn_trp = kyn / trp if trp > 0 else 0
    # Age-adjusted normative KYN/TRP
    norm_kyn_trp = adj_kyn_mean / adj_trp_mean if adj_trp_mean > 0 else norms[kyn_key]['mean'] / norms[trp_key]['mean']
    kyn_trp_z = (kyn_trp - norm_kyn_trp) / (norm_kyn_trp * 0.25)  # ~25% CV

    # Composite risk: low TRP + high KYN + high ratio = high risk
    # TRP below normal = bad â†’ invert sign
    composite = (-trp_z + kyn_z + kyn_trp_z) / 3

    if composite > 1.5:
        level = 'HIGH'
        color = '#E74C3C'
        interpretation = 'Significant KP dysregulation. Elevated neurotoxic shift. Consider intervention.'
    elif composite > 0.5:
        level = 'MODERATE'
        color = '#F39C12'
        interpretation = 'Moderate KP activation. Monitor and consider targeted intervention if symptomatic.'
    elif composite > -0.5:
        level = 'LOW-MODERATE'
        color = '#F1C40F'
        interpretation = 'Mild KP changes consistent with normal perimenopause transition.'
    else:
        level = 'LOW'
        color = '#27AE60'
        interpretation = 'KP within normal range. Standard menopause management recommended.'

    return {
        'trp_z': round(trp_z, 2),
        'kyn_z': round(kyn_z, 2),
        'kyn_trp': round(kyn_trp, 4),
        'kyn_trp_z': round(kyn_trp_z, 2),
        'composite': round(composite, 2),
        'level': level,
        'color': color,
        'interpretation': interpretation,
        'norm_trp': norms[trp_key]['mean'],
        'norm_kyn': norms[kyn_key]['mean'],
        'adj_trp': round(adj_trp_mean, 2),
        'adj_kyn': round(adj_kyn_mean, 2),
        'norm_kyn_trp': round(norm_kyn_trp, 4),
    }

def age_adjust(age, base_mean, beta):
    """Age-adjust a normative value using regression coefficient."""
    # Centered at mean study age 47.35
    return base_mean + beta * (age - 47.35)

def recommend_treatment(kp_result, symptoms, age, stage):
    """Generate treatment pathway recommendation based on KP profile + symptoms."""
    recommendations = []
    scores = {}

    for tx_name, tx in TREATMENTS.items():
        score = 50  # Base score

        # KP risk level adjustments
        if kp_result['level'] == 'HIGH':
            if tx_name == 'iTBS':
                score += 30  # Strong KP dysregulation â†’ brain stimulation most targeted
            elif tx_name == 'MHT (HRT)':
                score += 20  # Estrogen modulates KP
            elif tx_name == 'Monitoring Only':
                score -= 20
        elif kp_result['level'] == 'MODERATE':
            if tx_name == 'MHT (HRT)':
                score += 20
            elif tx_name == 'iTBS':
                score += 10
        elif kp_result['level'] == 'LOW':
            if tx_name == 'Monitoring Only':
                score += 20
            elif tx_name == 'iTBS':
                score -= 15

        # Symptom adjustments
        if 'Cognitive fog' in symptoms:
            if tx_name == 'iTBS':
                score += 15
            elif tx_name == 'SSRI/SNRI':
                score -= 10  # May worsen cognitive symptoms
        if 'Depression' in symptoms:
            if tx_name in ('SSRI/SNRI', 'CBT (Better Access)'):
                score += 15
            if tx_name == 'iTBS':
                score += 10
        if 'Anxiety' in symptoms:
            if tx_name in ('SSRI/SNRI', 'CBT (Better Access)'):
                score += 10
        if 'Hot flushes/VMS' in symptoms:
            if tx_name == 'MHT (HRT)':
                score += 25  # First-line for VMS
        if 'Sleep disturbance' in symptoms:
            if tx_name == 'MHT (HRT)':
                score += 10
            if tx_name == 'CBT (Better Access)':
                score += 5

        # Menopausal stage
        if stage == 'Late perimenopause':
            if tx_name == 'MHT (HRT)':
                score += 10  # Critical window
        elif stage == 'Early postmenopause':
            if tx_name == 'MHT (HRT)':
                score += 5
        elif stage == 'Late postmenopause (>5yr)':
            if tx_name == 'MHT (HRT)':
                score -= 15  # Past critical window
            if tx_name == 'Monitoring Only':
                score += 10  # Cognitive symptoms often resolve

        # Age factor
        if age > 55:
            if tx_name == 'Monitoring Only':
                score += 5  # Closer to resolution

        scores[tx_name] = max(0, min(100, score))

    # Sort by score
    ranked = sorted(scores.items(), key=lambda x: -x[1])
    return ranked, scores

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# SIDEBAR
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

st.sidebar.title("Patient Profile")

st.sidebar.markdown("**Demographics**")
age = st.sidebar.slider("Age", 40, 65, 51, help="Patient age in years")
stage = st.sidebar.selectbox("Menopausal Stage", [
    'Early perimenopause',
    'Late perimenopause',
    'Early postmenopause (<5yr)',
    'Late postmenopause (>5yr)',
    'Surgical menopause',
], index=1)

st.sidebar.divider()
st.sidebar.markdown("**Symptoms** (select all that apply)")
symptom_options = [
    'Cognitive fog',
    'Memory problems',
    'Depression',
    'Anxiety',
    'Hot flushes/VMS',
    'Sleep disturbance',
    'Fatigue',
    'Difficulty concentrating at work',
]
symptoms = []
for s in symptom_options:
    if st.sidebar.checkbox(s, key=f'sym_{s}'):
        symptoms.append(s)

st.sidebar.divider()
st.sidebar.markdown("**KP Biomarkers** (if available)")
has_kp = st.sidebar.toggle("KP blood test results available", value=False,
    help="If the patient has had serum/plasma TRP and KYN measured")

sample_type = 'serum'
trp_val = 60.52
kyn_val = 1.96

if has_kp:
    sample_type = st.sidebar.selectbox("Sample type", ['serum', 'plasma'])
    norm_ref = NORM_AU[f'{sample_type}_trp']
    kyn_ref = NORM_AU[f'{sample_type}_kyn']
    trp_val = st.sidebar.number_input(
        f"TRP ({norm_ref['unit']})",
        min_value=5.0, max_value=150.0,
        value=norm_ref['mean'],
        step=1.0,
        help=f"AU normative: {norm_ref['mean']} Â± {norm_ref['sd']} {norm_ref['unit']}"
    )
    kyn_val = st.sidebar.number_input(
        f"KYN ({kyn_ref['unit']})",
        min_value=0.1, max_value=10.0,
        value=kyn_ref['mean'],
        step=0.1,
        help=f"AU normative: {kyn_ref['mean']} Â± {kyn_ref['sd']} {kyn_ref['unit']}"
    )

st.sidebar.divider()
st.sidebar.markdown("**Risk Factors**")
risk_factors = []
rf_options = [
    ('Early/surgical menopause (<45)', 'early_meno'),
    ('Family history of dementia', 'fam_dementia'),
    ('Bilateral oophorectomy', 'oophorectomy'),
    ('No current MHT use', 'no_mht'),
    ('History of depression', 'hx_depression'),
]
for label, key in rf_options:
    if st.sidebar.checkbox(label, key=f'rf_{key}'):
        risk_factors.append(label)

st.sidebar.divider()
st.sidebar.markdown("**Neuroimaging / Genetics** (if available)")
has_mri = st.sidebar.toggle("MRI neuroimaging available", value=False,
    help="If the patient has had brain MRI â€” enables ARIA-H risk scoring")

cmb_count = 0
has_wmh = False
has_siderosis = False
apoe_status = 'Unknown'

if has_mri:
    cmb_count = st.sidebar.number_input("Cerebral microbleeds (CMB count)", 0, 50, 0,
        help="Number of cerebral microbleeds on SWI/T2* MRI")
    has_wmh = st.sidebar.checkbox("White matter hyperintensities (Fazekas 2-3)", key='rf_wmh',
        help="Moderate-severe WMH on FLAIR MRI")
    has_siderosis = st.sidebar.checkbox("Superficial siderosis", key='rf_siderosis',
        help="Cortical superficial siderosis â€” marker of cerebral amyloid angiopathy")

apoe_status = st.sidebar.selectbox("APOE e4 status (if known)", [
    'Unknown', 'Non-carrier', 'Heterozygous (e3/e4)', 'Homozygous (e4/e4)'
], help="Apolipoprotein E genotype â€” strongest genetic risk factor for AD")

st.sidebar.divider()
use_au = st.sidebar.toggle("Use Australian normative ranges", value=True,
    help="Metri 2023: AU serum TRP 67.26Â±11.19 vs global 60.52Â±15.38")

st.sidebar.divider()
st.sidebar.markdown("**Foundation:** Metri et al. 2023")
st.sidebar.markdown("**COI Model:** Gannott 2025")
st.sidebar.markdown("**Trial:** MenoStim (Metri PhD)")
st.sidebar.caption("Research prototype. Not validated for clinical use.")

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# MAIN
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

st.title("Menopause KP-CDST")
st.markdown("*Kynurenine Pathway Clinical Decision Support â€” Menopausal Cognitive & Mood Symptoms*")

if not symptoms and not has_kp:
    st.info("Select symptoms and/or enter KP biomarker values in the sidebar to generate a clinical profile.")
    st.markdown("---")

    st.subheader("About This Tool")
    col1, col2, col3 = st.columns(3)
    col1.metric("KP Normative Studies", "120")
    col2.metric("Individuals", "8,089")
    col3.metric("Countries", "31")

    st.markdown("""
    This tool uses the **kynurenine pathway (KP) normative reference data** from
    Metri et al. (2023) to generate a personalised risk assessment for women
    experiencing menopausal cognitive and mood symptoms.

    **The Menopause-KP Connection:**
    - Women have significantly **lower baseline TRP** (Î² = âˆ’0.22, p=.012)
    - TRP **falls with age** (Î² = âˆ’0.74, p<.001) while KYN **rises** (Î² = 0.02, p<.001)
    - This shifts the pathway toward **neurotoxic metabolites** at precisely the menopause transition
    - KP dysregulation is linked to depression, dementia, CVD, and T2DM

    **Economic Context:**
    - National burden: **$41.9B AUD/yr** (first published COI model)
    - Per-woman productivity loss: **$25,917 AUD/yr** (Stromberg-adjusted)
    - KP screening cost: **$80 AUD** (standard pathology HPLC)
    - KP-targeted iTBS reduces cost per responder by **61%** vs unselected

    **Research Throughline:**
    1. KP normative data â†’ Metri et al. 2023 (diagnostic foundation)
    2. Complementary therapy landscape â†’ Metri et al. 2026, Climacteric (gap identification)
    3. iTBS for menopausal symptoms â†’ MenoStim trial, Metri PhD (intervention)
    4. Economic framework â†’ Gannott 2025 COI + BIM (commercial case)
    """)
    st.stop()

# â”€â”€ Compute KP score â”€â”€
kp = kp_risk_score(trp_val, kyn_val, sample_type, use_au, patient_age=age)

# â”€â”€ Compute treatment recommendations â”€â”€
ranked, scores = recommend_treatment(kp, symptoms, age, stage)

# â”€â”€ Header metrics â”€â”€
st.markdown("### Patient Summary")
col1, col2, col3, col4 = st.columns(4)
col1.metric("Age", f"{age} years")
col2.metric("Stage", stage.split('(')[0].strip())
col3.metric("Symptoms", f"{len(symptoms)}")
col4.metric("Risk Factors", f"{len(risk_factors)}")

st.markdown("---")

# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
# TABS
# â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

tab1, tab2, tab3, tab4, tab5, tab6 = st.tabs([
    "KP Risk Profile", "Treatment Pathway", "Cost Analysis",
    "Dementia Risk", "Research Gaps", "Clinical Summary"
])

# â”€â”€ TAB 1: KP Risk Profile â”€â”€
with tab1:
    st.subheader("Kynurenine Pathway Risk Assessment")

    if has_kp:
        # KP score display
        col1, col2, col3 = st.columns(3)
        col1.metric("KP Risk Level", kp['level'],
                    help="Based on composite of TRP z-score, KYN z-score, and KYN/TRP ratio")
        col2.metric("KYN/TRP Ratio", f"{kp['kyn_trp']:.4f}",
                    f"{'â†‘' if kp['kyn_trp'] > kp['norm_kyn_trp'] else 'â†“'} vs norm {kp['norm_kyn_trp']:.4f}")
        col3.metric("Composite Score", f"{kp['composite']:.2f}",
                    help=">1.5 = HIGH, 0.5-1.5 = MODERATE, -0.5-0.5 = LOW-MOD, <-0.5 = LOW")

        st.markdown(f"**Interpretation:** {kp['interpretation']}")

        # Z-score chart
        fig_z = go.Figure()
        labels = ['TRP (inverted)', 'KYN', 'KYN/TRP Ratio']
        values = [-kp['trp_z'], kp['kyn_z'], kp['kyn_trp_z']]
        colors = ['#E74C3C' if v > 1 else '#F39C12' if v > 0.5 else '#27AE60' for v in values]

        fig_z.add_trace(go.Bar(
            x=labels, y=values,
            marker_color=colors,
            text=[f"z = {v:.2f}" for v in values],
            textposition='outside',
        ))
        fig_z.add_hline(y=1.0, line_dash='dash', line_color='red',
                       annotation_text='Risk threshold (+1 SD)')
        fig_z.add_hline(y=0, line_color='gray')
        fig_z.update_layout(
            height=350, yaxis_title='Z-Score (deviation from normative)',
            title='KP Biomarker Profile vs Normative Range',
        )
        st.plotly_chart(fig_z, width='stretch')

        # Normative comparison table â€” AGE-ADJUSTED
        st.markdown(f"**Normative Comparison â€” Age-Adjusted to {age}yr (Metri et al. 2023 regression)**")
        ref_label = "Australian" if use_au else "Global"
        norms = NORM_AU if use_au else NORM
        comparison = pd.DataFrame([
            {
                'Metabolite': 'Tryptophan (TRP)',
                'Patient': f"{trp_val:.1f} Î¼M",
                f'Age-Adj Mean (age {age})': f"{kp['adj_trp']:.2f} Î¼M",
                f'{ref_label} Population Mean': f"{norms[f'{sample_type}_trp']['mean']:.2f} Î¼M",
                'Z-Score': f"{kp['trp_z']:+.2f}",
                'Status': 'âš ï¸ LOW' if kp['trp_z'] < -1 else 'âœ… Normal' if abs(kp['trp_z']) < 1 else 'â†‘ High',
            },
            {
                'Metabolite': 'Kynurenine (KYN)',
                'Patient': f"{kyn_val:.2f} Î¼M",
                f'Age-Adj Mean (age {age})': f"{kp['adj_kyn']:.2f} Î¼M",
                f'{ref_label} Population Mean': f"{norms[f'{sample_type}_kyn']['mean']:.2f} Î¼M",
                'Z-Score': f"{kp['kyn_z']:+.2f}",
                'Status': 'âš ï¸ HIGH' if kp['kyn_z'] > 1 else 'âœ… Normal' if abs(kp['kyn_z']) < 1 else 'â†“ Low',
            },
            {
                'Metabolite': 'KYN/TRP Ratio',
                'Patient': f"{kp['kyn_trp']:.4f}",
                f'Age-Adj Mean (age {age})': f"{kp['norm_kyn_trp']:.4f}",
                f'{ref_label} Population Mean': f"{norms[f'{sample_type}_kyn']['mean'] / norms[f'{sample_type}_trp']['mean']:.4f}",
                'Z-Score': f"{kp['kyn_trp_z']:+.2f}",
                'Status': 'âš ï¸ ELEVATED' if kp['kyn_trp_z'] > 1 else 'âœ… Normal' if abs(kp['kyn_trp_z']) < 1 else 'Low',
            },
        ])
        st.dataframe(comparison, width='stretch', hide_index=True)
        st.caption(f"Age adjustment: TRP Î²={AGE_EFFECTS[f'{sample_type}_trp']['beta']}/yr, "
                  f"KYN Î²={AGE_EFFECTS[f'{sample_type}_kyn']['beta']}/yr, "
                  f"centered at study mean age 47.35yr (Metri 2023)")

    else:
        st.warning("No KP biomarker data entered. Risk assessment is based on symptoms and demographics only.")
        st.markdown("""
        **To enhance this assessment:**
        - Order serum TRP and KYN (standard HPLC at any pathology lab, ~$80 AUD)
        - Results scored against Metri et al. (2023) normative ranges
        - KP-guided treatment selection reduces cost per responder by 61%
        """)

        # Age-based expected KP trajectory
        ages = list(range(40, 66))
        expected_trp = [age_adjust(a, NORM_AU['serum_trp']['mean'], AGE_EFFECTS['serum_trp']['beta']) for a in ages]
        expected_kyn = [age_adjust(a, NORM_AU['serum_kyn']['mean'], AGE_EFFECTS['serum_kyn']['beta']) for a in ages]

        fig_traj = go.Figure()
        fig_traj.add_trace(go.Scatter(x=ages, y=expected_trp, name='Expected TRP (Î¼M)',
                                      line=dict(color='#3498DB', width=3)))
        fig_traj.add_vline(x=age, line_dash='dash', line_color='red',
                          annotation_text=f'Patient age: {age}')
        fig_traj.update_layout(
            height=300, title='Expected Serum TRP Trajectory with Age (Metri 2023 regression)',
            xaxis_title='Age', yaxis_title='Serum TRP (Î¼M)',
        )
        st.plotly_chart(fig_traj, width='stretch')

    # Symptom profile
    st.markdown("---")
    st.markdown("**Symptom Profile**")
    if symptoms:
        cog_symptoms = [s for s in symptoms if s in ('Cognitive fog', 'Memory problems', 'Difficulty concentrating at work')]
        mood_symptoms = [s for s in symptoms if s in ('Depression', 'Anxiety')]
        physical = [s for s in symptoms if s not in cog_symptoms + mood_symptoms]

        col1, col2, col3 = st.columns(3)
        with col1:
            st.markdown("**Cognitive**")
            for s in cog_symptoms:
                st.markdown(f"- {s}")
            if not cog_symptoms:
                st.caption("None reported")
        with col2:
            st.markdown("**Mood**")
            for s in mood_symptoms:
                st.markdown(f"- {s}")
            if not mood_symptoms:
                st.caption("None reported")
        with col3:
            st.markdown("**Physical**")
            for s in physical:
                st.markdown(f"- {s}")
            if not physical:
                st.caption("None reported")
    else:
        st.caption("No symptoms selected")

# â”€â”€ TAB 2: Treatment Pathway â”€â”€
with tab2:
    st.subheader("Treatment Pathway Recommendation")
    st.caption("Ranked by clinical suitability score (symptoms + KP profile + menopausal stage)")

    # Horizontal bar chart
    tx_names = [r[0] for r in ranked]
    tx_scores = [r[1] for r in ranked]
    tx_colors = [TREATMENTS[t]['color'] for t in tx_names]

    fig_tx = go.Figure()
    fig_tx.add_trace(go.Bar(
        y=list(reversed(tx_names)),
        x=list(reversed(tx_scores)),
        orientation='h',
        marker_color=list(reversed(tx_colors)),
        text=[f"{s}/100" for s in reversed(tx_scores)],
        textposition='outside',
    ))
    fig_tx.update_layout(
        height=350,
        xaxis_title='Suitability Score',
        xaxis=dict(range=[0, 110]),
        margin=dict(l=10, r=80, t=30, b=40),
    )
    st.plotly_chart(fig_tx, width='stretch')

    # Detailed cards
    st.markdown("---")
    for i, (tx_name, score) in enumerate(ranked):
        tx = TREATMENTS[tx_name]
        rank_label = 'ğŸ¥‡' if i == 0 else 'ğŸ¥ˆ' if i == 1 else 'ğŸ¥‰' if i == 2 else f'#{i+1}'

        with st.expander(f"{rank_label} {tx_name} â€” Score: {score}/100", expanded=(i == 0)):
            col1, col2, col3, col4 = st.columns(4)
            col1.metric("Annual Cost", f"${tx['annual_cost']:,}")
            col2.metric("MBS Rebate", f"${tx['mbs_rebate']:,}")
            col3.metric("Patient OOP", f"${tx['oop']:,}")
            col4.metric("Evidence (Mood/Cog)", f"{tx['evidence_mood']}/{tx['evidence_cog']}")
            st.markdown(tx['desc'])

    # Radar chart â€” evidence comparison
    st.markdown("---")
    st.subheader("Evidence Profile Comparison")
    st.caption("Scores (0-10): higher = stronger evidence or better performance in that domain")

    radar_cats = ['Mood', 'Cognition', 'VMS', 'Cost-Eff.', 'Access', 'Safety']
    fig_radar = go.Figure()
    for tx_name in [r[0] for r in ranked[:3]]:  # Top 3 treatments
        ev = TX_EVIDENCE[tx_name]
        vals = [ev['mood'], ev['cognition'], ev['vms'], ev['cost_eff'], ev['access'], ev['safety']]
        fig_radar.add_trace(go.Scatterpolar(
            r=vals + [vals[0]],  # Close the polygon
            theta=radar_cats + [radar_cats[0]],
            fill='toself',
            name=tx_name,
            line=dict(color=TREATMENTS[tx_name]['color']),
            opacity=0.6,
        ))
    fig_radar.update_layout(
        polar=dict(radialaxis=dict(visible=True, range=[0, 10])),
        height=450, showlegend=True,
        title='Top 3 Treatments â€” Evidence Radar',
    )
    st.plotly_chart(fig_radar, width='stretch')

    # Key note about iTBS
    if ranked[0][0] == 'iTBS':
        st.info("**Note:** iTBS is the #1 recommendation based on this patient's KP profile. "
                "The MenoStim trial (Metri PhD, NICM HRI/WSU) is the FIRST to test iTBS for "
                "menopausal cognitive symptoms. Efficacy is NOT yet established.")

# â”€â”€ TAB 3: Cost Analysis â”€â”€
with tab3:
    st.subheader("Per-Patient Cost-Offset Analysis")

    # Stromberg decomposition
    st.markdown(f"**Annual productivity loss (Stromberg-adjusted): ${PER_WOMAN_INDIRECT:,} AUD**")
    st.caption("Stromberg et al. (2017); applied per Tewhaiti-Smith, Gannott et al. (2025)")

    with st.expander("Stromberg Decomposition (5 buckets)", expanded=False):
        strom_data = pd.DataFrame([
            {'Bucket': '1. Employee Absenteeism', 'AUD/yr': STROMBERG['Base_A'], 'Type': 'Employee'},
            {'Bucket': '2. Employer Replacement (SA=0.97)', 'AUD/yr': STROMBERG['Employer_A'], 'Type': 'Employer'},
            {'Bucket': '3. Employee Presenteeism', 'AUD/yr': STROMBERG['Base_P'], 'Type': 'Employee'},
            {'Bucket': '4. Employer Friction (SP=0.54)', 'AUD/yr': STROMBERG['Employer_P'], 'Type': 'Employer'},
            {'Bucket': '5. WEP (SWEP=0.72 x employer-side)', 'AUD/yr': STROMBERG['WEP'], 'Type': 'Employer'},
        ])
        fig_strom = go.Figure()
        colors = ['#3498DB' if t == 'Employee' else '#E67E22' for t in strom_data['Type']]
        fig_strom.add_trace(go.Bar(
            x=strom_data['Bucket'], y=strom_data['AUD/yr'],
            marker_color=colors,
            text=[f"${v:,}" for v in strom_data['AUD/yr']],
            textposition='outside',
        ))
        fig_strom.update_layout(
            height=350, yaxis_title='AUD/year per symptomatic employed woman',
            title='Productivity Loss Decomposition (Stromberg 2017)',
        )
        st.plotly_chart(fig_strom, width='stretch')
        st.caption("Blue = employee-side cost | Orange = employer-side cost. "
                   "WEP computed from employer-side values only (0.72 x [Employer_A + Employer_P]).")

    # Treatment cost vs offset for each option
    efficacy_assumptions = {
        'iTBS': 0.22 if (has_kp and kp['level'] in ('HIGH', 'MODERATE')) else 0.12,
        'MHT (HRT)': 0.15,
        'SSRI/SNRI': 0.10,
        'CBT (Better Access)': 0.08,
        'Monitoring Only': 0.03,
    }

    cost_data = []
    for tx_name, tx in TREATMENTS.items():
        eff = efficacy_assumptions[tx_name]
        offset = round(PER_WOMAN_INDIRECT * eff)
        net = tx['annual_cost'] - offset
        roi = round((offset / tx['annual_cost'] - 1) * 100, 1) if tx['annual_cost'] > 0 else 0
        be_years = round(tx['annual_cost'] / offset, 1) if offset > 0 else float('inf')
        cost_data.append({
            'Treatment': tx_name,
            'Annual Cost': tx['annual_cost'],
            'Assumed Efficacy': f"{eff:.0%}",
            'Productivity Offset': offset,
            'Net Annual': net,
            'Break-Even (yrs)': be_years,
        })

    df_cost = pd.DataFrame(cost_data)

    # Grouped bar: cost vs offset
    fig_cost = go.Figure()
    fig_cost.add_trace(go.Bar(
        name='Treatment Cost',
        x=df_cost['Treatment'],
        y=df_cost['Annual Cost'],
        marker_color='#E74C3C',
    ))
    fig_cost.add_trace(go.Bar(
        name='Productivity Offset',
        x=df_cost['Treatment'],
        y=df_cost['Productivity Offset'],
        marker_color='#27AE60',
    ))
    fig_cost.update_layout(
        height=400, barmode='group',
        yaxis_title='AUD/year',
        title='Treatment Cost vs Productivity Offset',
    )
    st.plotly_chart(fig_cost, width='stretch')

    st.dataframe(df_cost, width='stretch', hide_index=True)

    if has_kp and kp['level'] in ('HIGH', 'MODERATE'):
        st.success(f"**KP-targeted iTBS:** With biomarker selection, assumed efficacy rises from "
                  f"12% to 22%, making iTBS cost-offset at ${round(PER_WOMAN_INDIRECT * 0.22):,}/yr "
                  f"against a ${TREATMENTS['iTBS']['annual_cost']:,} annual cost.")

    # National scaling
    st.markdown("---")
    st.subheader("National Scaling (if treatment adopted)")
    uptake_pct = st.slider("Assumed uptake (% of eligible)", 0.5, 10.0, 2.0, 0.5)
    eligible = 360_000
    treated = round(eligible * uptake_pct / 100)
    top_tx = ranked[0][0]
    top_eff = efficacy_assumptions[top_tx]
    national_offset = treated * round(PER_WOMAN_INDIRECT * top_eff)
    national_cost = treated * TREATMENTS[top_tx]['annual_cost']
    national_net = national_cost - national_offset

    col1, col2, col3 = st.columns(3)
    col1.metric("Patients Treated", f"{treated:,}")
    col2.metric(f"National Offset ({top_tx})", f"${national_offset:,}")
    col3.metric("Net Budget Impact", f"${national_net:,}",
               delta=f"{'Cost' if national_net > 0 else 'Saving'}",
               delta_color='inverse')

# â”€â”€ TAB 4: Dementia Risk + ARIA-H â”€â”€
with tab4:
    st.subheader("Downstream Dementia Risk Assessment")
    st.caption("EXPLORATORY â€” Rocca et al. (2007, 2021) + Metri et al. (2023) + ARIA-H neurovascular risk")

    # â”€â”€ Classical risk factor scoring â”€â”€
    dementia_score = 0
    risk_items = []

    if 'Bilateral oophorectomy' in risk_factors:
        dementia_score += 3
        risk_items.append(('Bilateral oophorectomy <menopause', 'HR = 1.46', 'Rocca 2007', '+3'))
    if 'Early/surgical menopause (<45)' in risk_factors:
        dementia_score += 3
        risk_items.append(('Early menopause (<45)', 'aOR = 2.21 for MCI', 'Rocca 2021', '+3'))
    if 'Family history of dementia' in risk_factors:
        dementia_score += 2
        risk_items.append(('Family history', 'OR ~2.0', 'Literature', '+2'))
    if 'No current MHT use' in risk_factors:
        dementia_score += 1
        risk_items.append(('No MHT during critical window', '~30% risk reduction missed', 'Maki 2013', '+1'))
    if has_kp and kp['level'] == 'HIGH':
        dementia_score += 2
        risk_items.append(('KP dysregulation (HIGH)', 'Neurotoxic shift', 'Metri 2023 + Giil 2016', '+2'))
    elif has_kp and kp['level'] == 'MODERATE':
        dementia_score += 1
        risk_items.append(('KP activation (MODERATE)', 'Elevated KYN/TRP', 'Metri 2023', '+1'))
    if 'Cognitive fog' in symptoms or 'Memory problems' in symptoms:
        dementia_score += 1
        risk_items.append(('Current cognitive symptoms', 'Subjective', 'Self-report', '+1'))

    # â”€â”€ ARIA-H neurovascular scoring â”€â”€
    aria_score = 0
    if has_mri:
        if cmb_count >= 5:
            aria_score += 3
            risk_items.append(('Cerebral microbleeds (>=5)', f'{cmb_count} CMBs on MRI', 'ARIA-H literature', '+3'))
        elif cmb_count >= 1:
            aria_score += 2
            risk_items.append(('Cerebral microbleeds (1-4)', f'{cmb_count} CMBs on MRI', 'ARIA-H literature', '+2'))
        if has_wmh:
            aria_score += 2
            risk_items.append(('WMH (Fazekas 2-3)', 'BBB compromise marker', 'Cerebrovascular lit.', '+2'))
        if has_siderosis:
            aria_score += 3
            risk_items.append(('Superficial siderosis', 'CAA marker â€” high BBB vulnerability', 'ARIA-H literature', '+3'))

    if apoe_status == 'Homozygous (e4/e4)':
        aria_score += 3
        risk_items.append(('APOE e4/e4 homozygous', 'OR ~12 for AD; BBB permeability', 'Literature', '+3'))
    elif apoe_status == 'Heterozygous (e3/e4)':
        aria_score += 2
        risk_items.append(('APOE e3/e4 heterozygous', 'OR ~3.2 for AD', 'Literature', '+2'))

    total_score = dementia_score + aria_score
    max_score = 12 + 11  # Classical max 12 + ARIA max 11

    # â”€â”€ Neurovascular vulnerability composite â”€â”€
    if aria_score >= 5:
        nv_level = 'HIGH'
        nv_color = '#E74C3C'
    elif aria_score >= 2:
        nv_level = 'MODERATE'
        nv_color = '#F39C12'
    else:
        nv_level = 'LOW'
        nv_color = '#27AE60'

    # Combined risk level
    if total_score >= 10:
        risk_level = 'CRITICAL'
        risk_color = '#C0392B'
    elif total_score >= 6:
        risk_level = 'ELEVATED'
        risk_color = '#E74C3C'
    elif total_score >= 3:
        risk_level = 'MODERATE'
        risk_color = '#F39C12'
    else:
        risk_level = 'POPULATION-LEVEL'
        risk_color = '#27AE60'

    col1, col2, col3, col4 = st.columns(4)
    col1.metric("Classical Risk", f"{dementia_score}/12")
    col2.metric("ARIA-H / Neurovasc.", f"{aria_score}/11")
    col3.metric("Combined Score", f"{total_score}/23")
    col4.metric("Risk Level", risk_level)

    if risk_items:
        st.markdown("**Contributing Factors:**")
        df_risk = pd.DataFrame(risk_items, columns=['Factor', 'Effect Size', 'Source', 'Points'])
        st.dataframe(df_risk, width='stretch', hide_index=True)

    # â”€â”€ Triple-Hit Model â”€â”€
    st.markdown("---")
    st.subheader("The Triple-Hit Model")
    st.caption("Why menopause + KP dysregulation + neurovascular vulnerability = accelerated neurodegeneration")

    st.markdown("""
    **Hit 1 â€” Estrogen withdrawal:** BBB becomes more permeable at menopause
    (Bake & Segal 2007). Estrogen normally maintains tight junctions and limits
    neuroinflammatory infiltration. Loss recapitulates an aged BBB phenotype.

    **Hit 2 â€” KP dysregulation:** Elevated circulating kynurenine crosses the BBB
    via the L-system amino acid transporter. In the brain, microglia convert KYN â†’
    quinolinic acid (QUIN), an NMDA receptor agonist and excitotoxin. Metri et al.
    (2023) showed TRP falls and KYN rises with age â€” the steepest shift occurs at
    menopause.

    **Hit 3 â€” ARIA-H neurovascular vulnerability:** Cerebral microbleeds, WMH,
    and superficial siderosis indicate pre-existing BBB compromise. APOE e4 carriers
    have leakier vessels. In this population, KYN flux into the brain is amplified
    and QUIN-mediated excitotoxicity is compounded.

    **The intersection of all three hits defines the highest-risk, most cost-effective
    population to intervene in.**
    """)

    # Triple-hit funnel visualization
    fig_funnel = go.Figure(go.Funnel(
        y=['All perimenopausal women (2.5M)',
           'Symptomatic (cognitive/mood) (~1.4M)',
           'KP-dysregulated (~30%: 420K)',
           'ARIA-H positive (~12%: 50K)',
           'KP + ARIA-H overlap (~15-50K)'],
        x=[2_500_000, 1_400_000, 420_000, 50_000, 30_000],
        textinfo='value+text',
        marker=dict(color=['#27AE60', '#F1C40F', '#F39C12', '#E74C3C', '#C0392B']),
    ))
    fig_funnel.update_layout(
        height=400,
        title='Precision Medicine Funnel: Population to High-Risk Subgroup',
        margin=dict(l=10, r=10, t=40, b=10),
    )
    st.plotly_chart(fig_funnel, width='stretch')

    # â”€â”€ Cost Avoidance Calculator â”€â”€
    st.markdown("---")
    st.subheader("Dementia Cost Avoidance Model")
    st.caption("Precision targeting converts speculative population-level estimates into defensible subgroup economics")

    col1, col2 = st.columns(2)
    with col1:
        st.markdown("**Population-Level Estimate**")
        pop_af = st.slider("Population AF (%)", 1.0, 10.0, 3.0, 0.5,
            help="Menopause-attributable fraction for dementia â€” no published estimate exists (GAP)") / 100
        pop_n = 2_500_000
        pop_avoidable = round(pop_n * pop_af * DEMENTIA_LIFETIME_COST / 1e9, 1)
        st.metric("Population", f"{pop_n:,}")
        st.metric("Avoidable Lifetime Cost", f"${pop_avoidable:.1f}B AUD")
        st.caption(f"AF = {pop_af:.1%} | Source quality: D (GAP â€” no published data)")

    with col2:
        st.markdown("**Precision Subgroup (ARIA-H + KP-targeted)**")
        default_sub_af = 20.0 if nv_level == 'HIGH' else 12.0 if nv_level == 'MODERATE' else 5.0
        sub_af = st.slider("Subgroup AF (%)", 5.0, 40.0, default_sub_af, 1.0,
            help="Higher AF defensible in defined high-risk subgroup (Rocca HRs in surgical menopause)") / 100
        sub_n_slider = st.slider("High-risk subgroup size", 15_000, 125_000, 50_000, 5_000,
            help="ARIA-H+ and KP-dysregulated perimenopausal women")
        sub_avoidable = round(sub_n_slider * sub_af * DEMENTIA_LIFETIME_COST / 1e9, 1)
        st.metric("Avoidable Lifetime Cost", f"${sub_avoidable:.1f}B AUD")
        st.caption(f"AF = {sub_af:.0%} | Source quality: C (defensible, screenable population)")

    # Per-patient intervention value
    per_patient_value = round(sub_af * DEMENTIA_LIFETIME_COST)
    st.info(f"**Per-patient intervention value:** At {sub_af:.0%} AF, avoidable cost per patient is "
            f"**${per_patient_value:,} AUD** â€” against a treatment cost of $7,500/yr. "
            f"{'Strongly cost-effective' if per_patient_value > 50000 else 'Cost-effective'} "
            f"by any ICER threshold.")

    st.markdown("---")
    st.markdown("**KP Connection to Neurodegeneration (Metri et al. 2023):**")
    st.markdown("""
    The kynurenine pathway is a central mediator between neuroinflammation and neurodegeneration:
    - **Tryptophan** is degraded via KP â†’ **kynurenine** â†’ branch point
    - Neuroprotective branch: â†’ **kynurenic acid (KYNA)** (NMDA antagonist)
    - Neurotoxic branch: â†’ **3-HK** â†’ **quinolinic acid (QUIN)** (NMDA agonist, excitotoxin)
    - With aging and estrogen withdrawal, the balance shifts toward **QUIN** (Giil et al. 2016)
    - Metri et al. (2023) established the normative reference enabling detection of this shift
    - **ARIA-H markers indicate the BBB is already compromised** â€” QUIN flux amplified

    **Intervention during the critical window (perimenopause) may modify this trajectory.**
    """)

    st.warning("**EXPLORATORY:** Dementia risk scoring is not validated. The triple-hit model "
              "is hypothesis-generating. ARIA-H risk in KP-dysregulated perimenopausal women "
              "has never been studied â€” this is a fundable research question (see Research Gaps). "
              "The MenoStim trial can begin to answer it if MRI + KP bloods are collected.")

# â”€â”€ TAB 5: Research Gaps â”€â”€
with tab5:
    st.subheader("Research Gaps & Fundable Questions")
    st.caption("Where Metri's research fills evidence gaps â€” and what remains to be answered")

    st.markdown("""
    Every **GAP** estimate in the COI/BIM model represents a **fundable research question**.
    The MenoStim trial (n=72) can answer several of these directly. Others require
    larger cohorts or data linkage studies.
    """)

    for i, gap in enumerate(RESEARCH_GAPS):
        priority_color = {'CRITICAL': 'ğŸ”´', 'HIGH': 'ğŸŸ ', 'MEDIUM': 'ğŸŸ¡'}.get(gap['priority'], 'âšª')
        with st.expander(f"{priority_color} {gap['gap']} [{gap['priority']}]", expanded=(i < 2)):
            col1, col2 = st.columns(2)
            with col1:
                st.markdown(f"**Current evidence:** {gap['current']}")
                st.markdown(f"**What it fills:** {gap['fills']}")
            with col2:
                st.markdown(f"**Fundable study:** {gap['fundable']}")
                st.markdown(f"**Who can answer it:** {gap['owner']}")

    st.markdown("---")
    st.subheader("The Grant Narrative")
    st.markdown("""
    **NHMRC / MRFF application structure:**

    1. **Burden:** $41.9B AUD/yr national cost of menopausal cognitive & mood symptoms
       (Gannott 2025 â€” first published COI)
    2. **Mechanism:** KP dysregulation accelerates at menopause â€” lower TRP, rising KYN,
       neurotoxic shift (Metri et al. 2023; Giil et al. 2016)
    3. **Gap:** No validated intervention for menopausal cognitive symptoms;
       complementary therapy evidence is low/very low (Metri et al. 2026)
    4. **Intervention:** iTBS â€” first trial for this indication (MenoStim, Metri PhD)
    5. **Biomarker:** KP profiling enables targeted patient selection
       (cost per responder drops 61% with biomarker guidance)
    6. **Translation:** CDST algorithm converts research into clinical tool
    7. **Economic case:** BIM shows KP-targeted iTBS is near cost-neutral within 5 years

    **Key question for Phase III funding:**
    *"Does iTBS in KP-dysregulated perimenopausal women modify the kynurenine-neurodegeneration
    trajectory and reduce cognitive/mood symptom burden?"*

    If MenoStim collects pre/post KP biomarkers, the pilot alone can establish
    whether iTBS shifts the KYN/TRP ratio â€” the mechanistic proof needed for a
    larger efficacy trial.
    """)

# â”€â”€ TAB 6: Clinical Summary â”€â”€
with tab6:
    st.subheader("Clinical Summary Report")

    # Generate summary text
    summary_lines = []
    summary_lines.append(f"**Patient:** {age}yo female, {stage}")
    summary_lines.append(f"**Symptoms:** {', '.join(symptoms) if symptoms else 'None reported'}")
    summary_lines.append(f"**Risk Factors:** {', '.join(risk_factors) if risk_factors else 'None'}")

    if has_kp:
        summary_lines.append(f"**KP Biomarkers ({sample_type}):** TRP {trp_val:.1f} Î¼M, KYN {kyn_val:.2f} Î¼M, KYN/TRP {kp['kyn_trp']:.4f}")
        summary_lines.append(f"**KP Risk Level:** {kp['level']} (composite z = {kp['composite']:.2f})")
        summary_lines.append(f"**Interpretation:** {kp['interpretation']}")
    else:
        summary_lines.append("**KP Biomarkers:** Not available â€” recommend serum TRP/KYN ($80 AUD)")

    summary_lines.append("")
    summary_lines.append(f"**Recommended Treatment:** {ranked[0][0]} (score {ranked[0][1]}/100)")
    summary_lines.append(f"**Alternative:** {ranked[1][0]} (score {ranked[1][1]}/100)")
    summary_lines.append("")
    summary_lines.append(f"**Estimated annual productivity loss:** ${PER_WOMAN_INDIRECT:,} AUD")
    eff = efficacy_assumptions[ranked[0][0]]
    summary_lines.append(f"**Potential offset with {ranked[0][0]}:** ${round(PER_WOMAN_INDIRECT * eff):,} AUD ({eff:.0%} improvement)")
    summary_lines.append("")
    summary_lines.append(f"**Dementia risk score:** {total_score}/23 ({risk_level})")
    summary_lines.append(f"  Classical: {dementia_score}/12 | ARIA-H/Neurovasc: {aria_score}/11")
    if nv_level != 'LOW':
        summary_lines.append(f"  Neurovascular vulnerability: {nv_level}")
    if has_mri and cmb_count > 0:
        summary_lines.append(f"  CMBs: {cmb_count} | WMH: {'Yes' if has_wmh else 'No'} | Siderosis: {'Yes' if has_siderosis else 'No'}")
    if apoe_status not in ('Unknown', 'Non-carrier'):
        summary_lines.append(f"  APOE: {apoe_status}")

    for line in summary_lines:
        st.markdown(line)

    st.markdown("---")
    st.markdown("**References:**")
    st.markdown("""
    - Metri NJ, et al. (2023). Normative data on serum/plasma TRP and KYN. *Int J Tryptophan Res*, 16. (KP normative)
    - Metri NJ, et al. (2026). Complementary therapies for menopausal symptoms. *Climacteric*. (Therapy landscape)
    - Metri NJ, et al. (2025). The MenoStim Trial. ACTRN12625000030471. (iTBS pilot)
    - Gannott M (2025). COI: Menopausal Cognitive & Mood Symptoms in Australia. (Economic model)
    - Tewhaiti-Smith JMK, Gannott M, et al. (2025). Cost of Endometriosis and CPP in NZ. *Women (MDPI)*. (Stromberg method)
    - Rocca WA, et al. (2007, 2021). Oophorectomy and dementia risk. *Neurology; JAMA Netw Open*. (Dementia pathway)
    - Maki PM (2013). Critical window hypothesis. *Menopause*. (HRT timing)
    - Bake S, Segal M (2007). 17Î²-estradiol differentially regulates BBB permeability. *Endocrinology*. (BBB + estrogen)
    - Giil LM, et al. (2016). KP metabolites in dementia. (KP â†’ neurodegeneration)
    - Guillemin GJ (2012). Quinolinic acid neurotoxicity review. (QUIN excitotoxicity)
    """)

    # Copy-friendly text
    st.markdown("---")
    plain_text = "\n".join([line.replace('**', '') for line in summary_lines])
    st.text_area("Copy-friendly text:", value=plain_text, height=300)

# â”€â”€ Footer â”€â”€
st.markdown("---")
st.markdown("""
<div style='text-align: center; color: #7f8c8d; font-size: 0.85em;'>
<b>Menopause KP-CDST v1.0</b><br>
KP Normative Data: Metri et al. 2023 (Int J Tryptophan Res, N=8,089)<br>
COI Model: Gannott 2025 (First published model) | Stromberg: Tewhaiti-Smith, Gannott et al. 2025<br>
ARIA-H Triple-Hit Model: Bake & Segal 2007; Giil 2016; Guillemin 2012<br>
Trial: MenoStim (Metri PhD, NICM HRI, WSU) â€” ACTRN12625000030471<br>
<br>
<b>Research prototype â€” not validated for clinical use.</b><br>
For clinical decision support only. Not a substitute for clinical judgement.
</div>
""", unsafe_allow_html=True)
